A single-arm, prospective, multicentre, open-label study to evaluate ofatumumab treatment effectiveness and patient-reported outcomes in patients with relapsing multiple sclerosis transitioning from dimethyl fumarate or fingolimod therapy.
Location: PAMF (Peninsula/South Bay/Santa Cruz)
Please contact: Renee Kaneshiro at firstname.lastname@example.org about Artios
Using Electronic Health Records to Identify Gaps in Migraine Headache Care: A Step Towards Improving Patient Outcomes
Investigator: Sylvia Sudat, PhD